Search
Element Search
Structure Search
Thermo Scientific Chemicals
3,5-Di-tert-butyl-4-hydroxybenzaldehyde, 98+%
CAS: 1620-98-0 | C15H22O2 | 234.339 g/mol
Have Questions?
Change view
Catalog number A15864.14
also known as A15864-14
Price (EUR)
97,00
Each
Quantity:
25 g
Price (EUR)
97,00
Each
Chemical Identifiers
CAS1620-98-0
IUPAC Name3,5-di-tert-butyl-4-hydroxybenzaldehyde
Molecular FormulaC15H22O2
InChI KeyDOZRDZLFLOODMB-UHFFFAOYSA-N
SMILESCC(C)(C)C1=CC(C=O)=CC(=C1O)C(C)(C)C
View more
Specifications
Specification Sheet
Specification SheetAppearance (Color)White to cream or pale yellow to yellow
FormCrystals or powder or crystalline powder or flakes
Assay (GC)≥98.0%
Identification (FTIR)Conforms
Melting Point (clear melt)185-193°C
3,5-Di-tert-butyl-4-hydroxybenzaldehyde is employed as an OLED materials. It is also used as a pharmaceutical intermediate. The derivatives of this compound possess equipotent anti-inflammatory activities to indomethacin.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
3,5-Di-tert-butyl-4-hydroxybenzaldehyde is employed as an OLED materials. It is also used as a pharmaceutical intermediate. The derivatives of this compound possess equipotent anti-inflammatory activities to indomethacin.
Solubility
Soluble in hot methanol.
Notes
Air sensitive. Store at room temperature. Keep away from oxidizing agents.
3,5-Di-tert-butyl-4-hydroxybenzaldehyde is employed as an OLED materials. It is also used as a pharmaceutical intermediate. The derivatives of this compound possess equipotent anti-inflammatory activities to indomethacin.
Solubility
Soluble in hot methanol.
Notes
Air sensitive. Store at room temperature. Keep away from oxidizing agents.
RUO – Research Use Only
Michael D. Mullican.; Michael W. Wilson.; David T. Conner.; Catherine R. Kostlan.; Denis J. Schrier.; Richard D. Dyer. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents.J. Med. Chem. 1993, 36 (8),1090-1099 .